Asthma, Bronchial Clinical Trial
Official title:
A Double-Blind, Double-Dummy, Randomized, Placebo-Controlled, 2-Arm, 2X2 Crossover Study Comparing the Effects of Montelukast, Inhaled Budesonide, and Placebo on Lower Leg Growth in Children (Prepubertal, Tanner Stage I) With Mild Asthma
The purpose of this study is to determine the effect of montelukast, an approved medication, on the lower leg growth rate in children with mild asthma. The primary hypothesis is that the lower leg length (LLL) growth rate for children treated with montelukast compared to placebo will be established.
This is a crossover study that consists of a 2-week placebo run-in period, then a first 3-week treatment period, then a 2-week washout period, and then a second 3-week treatment period. Participants will be randomized to treatment with either montelukast and placebo or budesonide and placebo. The duration of treatment is 6 weeks. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00825903 -
The Effects of Exercise on Physiological and Psychological Parameters in an Asthmatic Population
|
N/A | |
| Completed |
NCT00734318 -
Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma
|
Phase 3 | |
| Terminated |
NCT00385593 -
Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
|
Phase 3 | |
| Completed |
NCT00213252 -
Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma
|
Phase 2 | |
| Completed |
NCT00489346 -
A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)
|
Phase 3 | |
| Withdrawn |
NCT03989635 -
Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.
|
Phase 2 | |
| Withdrawn |
NCT00540839 -
A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
|
Phase 3 | |
| Recruiting |
NCT06299306 -
REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma
|
||
| Recruiting |
NCT00312312 -
Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide
|
N/A | |
| Completed |
NCT00092885 -
An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)
|
Phase 3 | |
| Not yet recruiting |
NCT06422078 -
A Non-interventional, Prospective Study With Benralizumab
|
||
| Completed |
NCT02805907 -
Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)
|
Phase 4 | |
| Not yet recruiting |
NCT00644462 -
Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording
|
N/A | |
| Completed |
NCT03839433 -
The Mannitol-Asthma-Ciclesonide-Study
|
Phase 4 | |
| Completed |
NCT00640120 -
Wheeze Detection in Children During Dynamic Bronchial Situations Measured by WIM-PC™ Recording
|
N/A | |
| Recruiting |
NCT05937334 -
The Cohort Study for Asthma in China
|
||
| Completed |
NCT03034447 -
Sleep Apnea in Asthmatic Children and Teenagers
|
N/A | |
| Completed |
NCT05270278 -
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
|
||
| Withdrawn |
NCT00830427 -
A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects
|
Phase 2 | |
| Completed |
NCT00092105 -
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
|
Phase 3 |